Live Breaking News & Updates on Vetsynova co

Stay informed with the latest breaking news from Vetsynova co on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vetsynova co and stay connected to the pulse of your community

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results
|
0
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care,
eye, oral and nasal care and dermatological conditions today announced financial results for fiscal year 2021 and the fourth quarter ended March 31, 2021.
“For the past 18 months we have been restructuring the Company to cut losses while positioning it for growth,” said Amy Trombly, CEO. “Last year we consolidated all manufacturing at our factory in
Mexico (June), and ended our contract with Invekra that required us to sell product with low margin (October). This year, we entered into a partnership agreement with EMC Pharma, LLC for the sale

Germany , Georgia , United-states , New-zealand , Thailand , Hong-kong , Netherlands , Egypt , Roermond , Limburg , Portugal , France

Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn® Disinfecting Solution is Now Available in Hong Kong and Thailand

Press release content from Business Wire. The AP news staff was not involved in its creation.
Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn® Disinfecting Solution is Now Available in Hong Kong and Thailand
January 28, 2021 GMT
WOODSTOCK, Ga.--(BUSINESS WIRE)--Jan 28, 2021--
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, disinfectant use and dermatological conditions, and Microderm Technologies Ltd. announce that Dermodacyn® disinfectant has received import clearance as a medical device for Thailand with the help from Microderm’s partner VetSynova Co. Ltd., Thailand, and is now available online and in pharmacies and stores in Hong Kong and Thailand.

United-states , Thailand , Hong-kong , University-of-hong-kong , Hong-kong-general , Amy-trombly , Christopher-lee , Sonoma-microcyn , Exchange-commission , Sonoma-pharmaceuticals-inc , Vetsynova-co , Sonoma-pharmaceuticals

Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn Disinfecting Solution is Now Available in Hong Kong and Thailand

Posted on
8440
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, disinfectant use and dermatological conditions, and Microderm Technologies Ltd. announce that Dermodacyn® disinfectant has received import clearance as a medical device for Thailand with the help from Microderm’s partner VetSynova Co. Ltd., Thailand, and is now available online and in pharmacies and stores in Hong Kong and Thailand.
Dermodacyn disinfecting solution is designed to be sprayed as an aerosol to disinfect areas suspected to contain bacteria and viruses that can lead to disease. Dermodacyn disinfectant is medical grade and can be used in hospitals to keep doctors and patients protected and safe. It also performs well in other high traffic areas that require constant cleaning and disinfecting. In a study by the University of Hong Kong and Queen Mary Hospital Dermodacyn disinfecting solution showed it effectively kills the coronavirus SARS-CoV-2. See https://www.journalofhospitalinfection.com/article/S0195-6701(20)30339-X/fulltext.

Georgia , United-states , Thailand , Netherlands , Hong-kong , University-of-hong-kong , Hong-kong-general , Roermond , Limburg , America , Amy-trombly , Christopher-lee